Tumor Marker Testing Technologies and Strategic Profiles of Leading Suppliers
This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for tumor markers technologies. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.
More Publications
2015 Tumor Markers Testing Market: Strategic Assessments of Major Suppliers
US$ 2,000.00
July 2015
80 pages
2015 Competitive Intelligence: Global Tumor Marker Testing Market - Strategic Assessments of Major Suppliers and Emerging Market Entrants
US$ 2,000.00
August 2015
80 pages
2017-2021 Emerging Opportunities in the Tumor Markers Testing Market: Strategic Assessments of Major Suppliers
US$ 2,250.00
February 2017
80 pages
2016 Global Tumor Marker Testing Market - Strategic Assessments of Major Suppliers and Emerging Market Entrants
US$ 2,000.00
October 2015
80 pages
2016-2020 Emerging Opportunities in the Tumor Markers Testing Market: Strategic Assessments of Major Suppliers
US$ 2,000.00
March 2016
80 pages
